Skip to content

Versalok Anchor with Free Strands of Orthocord Suture (210808), Ethibond Suture (210809), and Panacryl Suture (210810)

by Depuy Mitek, A Johnson & Johnson Company

510(k) K063478

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK063478 Date15 Dec 2006ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
HWC
Device Class
Class II
Regulation
21 CFR Part 888.3040
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Versalok Anchor is a metallic bone fixation fastener used for soft tissue-to-bone attachment. It consists of the anchor pre-mounted on an inserter shaft with an anvil, a threader tab, and #2 suture (Orthocord, Panacryl, or Ethibond).

The device is deployed using a reusable deployment gun. It is supplied with specific suture variants identified by model numbers 210808, 210809, and 210810. The device received FDA 510(k) clearance under K063478 with product code HWC and was determined to be substantially equivalent on December 15, 2006.

Other devices from Depuy Mitek, A Johnson & Johnson Company

See all devices from Depuy Mitek, A Johnson & Johnson Company →

Questions

AI-generated answers, 19 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What types of suture materials are available with the Versalok Anchor, and how do they differ in application?

    The Versalok Anchor is available with three suture types: Orthocord (model 210808), Ethibond (model 210809), and Panacryl (model 210810). Orthocord is a braided polyester suture known for its strength and flexibility, ideal for soft tissue repair requiring durability. Ethibond is a braided polyester suture with a higher tensile strength, often used for long-term stability in orthopedic procedures. Panacryl is a braided polyester suture with a monofilament core, offering a balance of strength and reduced tissue reactivity, suitable for applications where a smoother pull is beneficial.

  • Is the Versalok Anchor system single-use or reusable, and how is it deployed?

    The Versalok Anchor itself is designed for single-use, as it is a metallic bone fixation fastener intended for one-time implantation. Deployment is achieved using a reusable deployment gun, which allows for repeated use across multiple anchors. The inserter shaft, anvil, and threader tab are part of the disposable anchor system, while the deployment gun is engineered for durability and multiple procedures.

  • What are the key differences between the three model numbers (210808, 210809, 210810) of the Versalok Anchor?

    The three model numbers correspond to the type of suture pre-mounted on the anchor: model 210808 uses Orthocord suture, 210809 uses Ethibond suture, and 210810 uses Panacryl suture. The only functional difference lies in the suture material itself, which affects properties like tensile strength, tissue reactivity, and absorption characteristics. The anchor mechanism and deployment process remain identical across all three models.

  • How was the Versalok Anchor determined to be substantially equivalent, and what does this mean for its use in clinical settings?

    The Versalok Anchor received FDA 510(k) clearance under K063478 with a determination of substantial equivalence (SESE) on December 15, 2006, under the orthopedic product code HWC. This means the device was compared to a legally marketed predicate and found to have the same intended use, technological characteristics, and performance as the predicate device. Clinically, this clearance indicates that the device meets regulatory standards for safety and effectiveness, but it does not imply any specific indication or limitation beyond what was evaluated in the submission.